Biobanks Market - Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MDC Research
Pune, May 23, 2022 (GLOBE NEWSWIRE) -- According to report of Market Data Centre, Biobanks industry gathered revenue worth USD 67.5 billion in 2021 and is slated to accumulate returns of approx. USD 105.17 billion by 2030. In addition to this, Biobanks market is set to register CAGR of nearly 5.4% in 2022-2030. Moreover, biobanks are a key part of precision medicine and strongly support population stratification & biomarker drug discovery. They have become key resources for biomedical & genetic research activities. These biobanks provide bio-specimens utilized for elucidating pathophysiology & diagnosis of diseases, thereby helping in more apt disease treatment. All these aforementioned aspects will boost size of biobanks market over 2022-2030.
Download free Sample PDF https://www.marketdatacentre.com/samplepdf/15208
Reportedly, sixteen of largest biobanks in Europe, Australia, Asia, and North America have been collecting & distributing human research specimens along with proficiently handling scientific initiatives with a reduction in operational costs. With large number of commercial & academic biobanks aiding large clinical & epidemiological studies, the market for biobanks is projected to gain traction over forecasting timeframe. Moreover, biobanks have played a major role in disease prediction in individuals, therapy monitoring, follow-up, and optimization, thereby harnessing growth of biobanks market.
Furthermore, biobanks offer a multi-disciplinary approach useful in addressing health issues in human beings. It also offers medical & biological approaches in synchronization with informative bioinformatics systems, modeling, and computation. In addition to this, biobanks enhance efficacy of diagnostics research, pharmacology research, and other kinds of scientific research activities. Apparently, biobanks help in a comprehensive analysis of particular disease occurring due to biological disorder or heredity. This, in turn, will create new growth avenues for biobanks market.
Biobanking Equipment Segment To Establish Hegemony In Biobanks Market Over Forecast Period (2022-2030)
Rapid expansion of biobanking equipment segment over assessment period can be credited to massive need for product for catering to requirement of biobanking processes including preparation of samples, collecting of samples, processing of samples, and storing & shipment of samples. Increase in proportion of biobanks will lead to escalation in demand for biobanks, thereby embellishing demand for biobanking equipment.
Human Tissues To Dominate Service Domain Space By 2030
Growth of human tissues segment over forecasting period can be attributed to easy access to human tissue samples and availability of new technologies for storing & retrieving biobanked tissues. A prominent surge in funding of biotech research focussing on cure of chronic disorders will foster demand for human tissue samples for study of oncology.
Get a Sample Copy of the Report https://www.marketdatacentre.com/sample/15208
Europe To Contribute Major Revenue Share Towards Biobanks Market In Forecast Timeline
Progression of European Biobanks Industry over forecasting timeline is subject to a prominent surge in funding of healthcare activities in continent. In addition to this, need for addressing disease management issues in region has resulted in ascension of market growth in Europe. Citing an instance, in March 2019, the UK based biobanks produced exome sequence data from nearly fifty thousand persons with an objective of addressing healthcare-related issues such as disease prevention, diagnosis, and cure through medical treatment.
Some of key players have strongly leveraged growth of biobanks market and will continue to do so even in foreseeable future. They are
Thermo Fisher Scientific, Inc.
Tecan Trading AG
Becton, Dickinson and Company
Charles River Laboratories International, Inc.
STEMCELL Technologies Inc.
Biovault Family Limited
Precision Cellular Storage Ltd.
Breakthroughs in Biobanks Market
In May 2022, BC Platforms – a leader in healthcare data management & analytics- has declared to secure a long-term contract with three Finnish Hospital District-owned clinical biobanks for improving access to genomic, phenotypic, and clinical data. Moreover, the strategic move is aimed at bringing an improvement in medical treatment along with focusing on effective research, diagnosis, and treatment of cancer and neuro-generative disorders
This review is based on a report by Market Centre, titled,” Biobanks Market - Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MDC Research.”
Read Overview of the Report https://www.marketdatacentre.com/biobanks-market-15208
The global biobanks Market is segmented as follows:
By Biospecimen Type
By Biobank Type
Biobanking & Repository
Cold Chain Logistics
Drug Discovery & Clinical Research
Rest of Europe
Rest of Southeast Asia
Rest of Southeast Asia
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Key Questions Answered in This Report:
How does our product and services portfolio compare to leading competitors?
What are the key developments in customer demand given the changing economy?
What are the new pricing and consumption models in the marketplace and how should we align our portfolio?
What are the key decision drivers for services buyers?
How can we accelerate our bidding process?
What is the potential of the Biobanks Market?
What is the impact of COVID-19 on the global Biobanks Market?
What are the top strategies that companies adopting in Biobanks Market?
What are the challenges faced by SME’s and prominent vendors in Biobanks Market?
Which region has the highest investments in Biobanks Market?
What are the latest research and activities in Biobanks Market?
Who are the prominent players in Biobanks Market?
What is the potential of the Biobanks Market?
At MDC Research, we offer research solutions to help businesses break the barriers of doubt or uncertainties when they plan to expand their growth. Our researchers compile data and information that help chief executive officers decide which growth opportunities in a market to pursue.
MDC Research is known for conducting well-researched reports, and the expertise of our researchers contributes to the outstanding quality of our reports. MDC Research enables businesses to make impactful decisions by blending innovation and analytical thinking. Our unique blend of these two skills assures you access to the most complete and up-to-date information about your industry.
Check the Discount on this Report https://www.marketdatacentre.com/discount/15208
Market Data Centre (Subsidiary of Yellow Bricks Global Services Private Limited)
Market Data Centre offers complete solutions for market research reports in miscellaneous businesses.These decisions making process depend on wider and systematic extremely important information created through extensive study as well as the most recent trends going on in the industry.The company also attempts to offer much better customer-friendly services and appropriate business information to achieve our clients’ ideas.
CONTACT: Market Data Centre (Subsidiary of Yellow Bricks Global Services Private Limited) Office 808, Amar Business Park, S.No. 105, Baner Road, Pune 411045, India Email: firstname.lastname@example.org Phone: +1-916-848-6986 (US) Website: https://www.marketdatacentre.com/